LB Pharmaceuticals Inc
Price
FilingsNewest: 424B3, ProspectusSep 15 →InsidersNo open-market buys or sales.→HoldersDeep Track Capital 11.7%BlackRock 9.5%Ra 7.7%→Financing →PeersClosest companies: NEUP, ANRO, MPLT→
From the filings
Figures
- Net income
- −$85.7Mlast 12 months
- Operating cash flow
- −$50.4Mlast 12 months
- Cash and equivalents
- $283.1Mat the last balance sheet
- Shares outstanding
- 28.7M shareson issue